Why Prioritize the Structure-Based Drug Design Summit – San Diego?
As the drive for smarter, faster, and more efficient drug discovery intensifies, leveraging structural insights across proteins, complexes, and multi-modal targets has never been more critical. Advances in Cryo-EM, X-ray crystallography, NMR, HDX-MS, and AI-driven modelling are enabling researchers to visualize dynamic targets, uncover hidden pockets, and guide rational design of small molecules, biologics, and complex modalities.
Built by biopharma for biopharma, the Structure-Based Drug Design Summit makes its West Coast debut in San Diego this February, bringing together structural biologists, medicinal chemists, computational chemists, and protein engineers to share best practices, explore real-world applications, and learn how to integrate structural and computational insights to optimize candidates, reduce attrition, and accelerate discovery.
Unmissable Event Highlights
Integrating the Structural Biology Toolbox
Gain practical strategies to integrate diverse structural and computational methods into cohesive drug design workflows, enabling more accurate decision-making, faster hit-to-lead optimization, and improved candidate selection across small molecules and biologics with Eli Lilly, Vertex & more!
Drive Smarter Optimization
Unlock effective strategies to optimize molecules more intelligently and efficiently by leveraging structural insights, from using NMR to reveal dynamics, to structurally guided ADME optimization that mitigates metabolic liabilities, ultimately reducing attrition and advancing more potent, selective, and developable candidates with Sanofi & Regeneron.
Explore Real-World Applications
See how peers across the industry are applying structure-based drug design to rationally engineer candidates, translating structural insights into smarter design decisions, improved selectivity, and accelerated discovery outcomes with MOMA Therapeutics, Structure Therapeutics and Foghorn Therapeutics.
Attending Companies Include